NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

PURPOSE: NANOG is a master transcription factor that regulates stem cell pluripotency and cellular reprograming. Increased NANOG expression has been associated with poor survival in several human malignancies. However, the clinical significance of NANOG overexpression in lung cancer has been scarcel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Boksoon, Park, Myung Jae, Choi, Sue In, In, Kwang Ho, Kim, Chul Hwan, Lee, Seung Hyeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614794/
https://www.ncbi.nlm.nih.gov/pubmed/29033581
http://dx.doi.org/10.2147/OTT.S144895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614794/
https://www.ncbi.nlm.nih.gov/pubmed/29033581
http://dx.doi.org/10.2147/OTT.S144895

Ejemplares similares